               SEQUENCE LISTING

<110> Cambridge Epigenetix Limited

<120> Improved nucleic acid sample preparation using concatenation

<150> GB1418621.7
<151> 2014-10-20

<160> 6

<170> BiSSAP 1.2

<210> 1
<211> 29
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..29
<223> /organism="Artificial Sequence"
      /note="Phi9 primer"
      /mol_type="unassigned DNA"

<400> 1
gccacgtatt ttgcaagcta tttaactgg                                      29


<210> 2
<211> 30
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..30
<223> /organism="Artificial Sequence"
      /note="Phi15 primer"
      /mol_type="unassigned DNA"

<400> 2
cgaaggggac gaaaaatggt ttttagagaa                                     30


<210> 3
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..24
<223> /organism="Artificial Sequence"
      /note="Phi2 primer"
      /mol_type="unassigned DNA"

<400> 3
tctttagtcg cagtaggcgg aaaa                                           24


<210> 4
<211> 57
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..57
<223> /organism="Artificial Sequence"
      /note="Phi2 primer extended"
      /mol_type="unassigned DNA"

<400> 4
tctttagtcg cgtaggcgga aaagaacaag cgcaagagta aacatagtgc catgctc        57


<210> 5
<211> 31
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..31
<223> /organism="Artificial Sequence"
      /note="Primer 10"
      /mol_type="unassigned DNA"

<400> 5
gatcggaaga gcacacgtct gaactccagt c                                   31


<210> 6
<211> 70
<212> DNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..70
<223> /organism="Artificial Sequence"
      /note="Primer 94"
      /mol_type="unassigned DNA"

<220> 
<221> misc_feature
<222> 65..70
<223> /note="n is a or g or c or t/u, unkown, or other"

<400> 6
caagcagaag acggcatacg agatgcggac gtgactggag ttcagacgtg tgctcttccg     60

atctnnnnnn                                                            70


